Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Erasmus Medical Center
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
In order to be eligible to participate in this study, a subject must meet all of the following criteria:
18 years of age or older;
Planned to start treatment with concomitant capecitabine and oxaliplatin according to standard of care (irrespective of dose);
Fit for treatment with capecitabine and oxaliplatin as judged by the treating physician;
Capable of understanding and complying with protocol requirements and able to understand and sign the informed consent form.
You may not be if
A potential subject who meets any of the following criteria will be excluded from participation in this study:
Carrier of a known clinically relevant DPYD variant (i.e. \*2A, \*7, \*13, c.1236G\>A or c.2846A\>T);
Any medical condition that is known to influence capecitabine absorption (i.e. a Roux-en-Y gastric bypass operation or complete gastric resection; an esophagectomy is not considered to impair absorption);
